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Abstract
Objectives To identify issues that facilitate the successful
integration of evaluation and development of telehealthcare
services.
Design Ethnographic study using various qualitative research
techniques to obtain data from several sources, including in-
depth semistructured interviews, project steering group
meetings, and public telehealthcare meetings.
Setting Seven telehealthcare evaluation projects (four
randomised controlled trials and three pragmatic service
evaluations) in the United Kingdom, studied over two years.
Projects spanned a range of specialties—dermatology,
psychiatry, respiratory medicine, cardiology, and oncology.
Participants Clinicians, managers, technical experts, and
researchers involved in the projects.
Results and discussion Key problems in successfully
integrating evaluation and service development in
telehealthcare are, firstly, defining existing clinical practices (and
anticipating changes) in ways that permit measurement;
secondly, managing additional workload and conflicting
responsibilities brought about by combining clinical and
research responsibilities (including managing risk); and, thirdly,
understanding various perspectives on effectiveness and the
limitations of evaluation results beyond the context of the
research study.
Conclusions Combined implementation and evaluation of
telehealthcare systems is complex, and is often underestimated.
The distinction between quantitative outcomes and the
workability of the system is important for producing evaluative
knowledge that is of practical value. More pragmatic
approaches to evaluation, that permit both quantitative and
qualitative methods, are required to improve the quality of such
research and its relevance for service provision in the NHS.
Introduction
The promise of telehealthcare is that it might revolutionise the
practice of medicine by enabling remote interaction between cli-
nicians and patients, through the use of information and
communications technologies such as interactive video, digital
imaging, and electronic data transmission.1 2 For policy makers
and clinicians, telehealthcare offers the potential to solve
problems of structural and spatial inequalities of access to
specialist care, and to increase the speed of referral and manage-
ment decisions.3
In practice, however, telehealthcare is somewhat contentious
and unstable.4 Although its proponents value the potential
organisational benefits it may bring, others express concern
about its implications for the practice of medicine, particularly in
relation to the doctor-patient interaction.5 Concerns about clini-
cal risk and potential litigation6 and, internationally, ongoing dif-
ficulties relating to licensure and reimbursement7 may add to the
resistance to telehealthcare in practice.
The production of evidence about the safety and effective-
ness of telehealthcare is therefore vital for its progression.
Although there have beenmany trials of telehealthcare in Britain
and elsewhere, such services typically fail to become part of rou-
tine healthcare delivery.8 This makes achieving sufficient levels of
use of telehealthcare services to provide meaningful evaluations
difficult.9 The existing evidence base for telehealthcare is
therefore not as strong as some of its champions have
suggested.10–12
Understanding how this evidence base is constructed is
important because there are concerns about the utility of apply-
ing medical models of evaluation to technological systems.13 14
Research suggests fundamental problems in integrating
telehealthcare into systems of professional practice in everyday
settings.15 16 Our study was intended to further understanding of
this knowledge production process by exploring the method-
ological issues that arise when integrating evaluation with the
(often experimental) development of telehealthcare services. We
identify lessons that may improve future evaluations of
telehealthcare to better inform the implementation of services.
Methods
Participants and settings
Between 2000 and 2002, we undertook an ethnographic study—
using a variety of qualitative techniques to study telehealthcare
projects and their development in depth and over time17—of fac-
tors that promote and inhibit the effective evaluation of
telehealthcare. We studied seven telehealthcare evaluation
projects in a variety of specialties—dermatology, psychiatry,
respiratory medicine, cardiology, and oncology. Projects were
chosen to represent good variability in specialties, settings, and
evaluation methods (see box 1 for details). We identified project
leaders from websites and databases and then asked them if we
could include their project in our study. With the help of project
leaders, we identified key informants within the project teams
and asked them if we could record interviews with them. We
obtained appropriate ethical approval and followed stringent
procedures to ensure the anonymity of participants.
Data collected
We conducted interviews with key informants (n = 76), recorded
steering group meetings and other meetings (n = 19), observed
the projects, and analysed project documents. Interviewees
included clinicians (nurses and physicians), researchers (princi-
pal investigators, research associates and assistants, health
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economists, and statisticians), and technical experts associated
with the specific projects. Participants were interviewed up to
four times (typically two or three times). All authors conducted at
least some interviews, as appropriate to each author’s areas of
expertise. We conducted the interviews in person at the site most
convenient for the respondent (typically either an NHS or
academic setting). We used a semistructured interview guide for
all initial interviews, with subsequent interviews designed more
specifically around the interviewee and project. Key themes for
questioning included the history of the project, organisational
relations between key participants, the purpose of or questions
for the evaluation, methods of evaluation, and positive and nega-
tive experiences of evaluation.
Data analysis
Formal data for the analysis presented in this paper were the
transcribed interviews. Although not presented here as data,
observation and project documentation supported and strength-
ened our interpretation of interview data.
Our analysis of interview material was guided by the broad
precepts of constant comparative analysis.18 The trustworthiness
of the data was established by involving all authors in data
interpretation and the development of analytical themes. Six
transcripts that varied greatly in perspective and content were
coded individually by all authors and then discussed in team
meetings. Within these meetings, we built a collaborative analysis
for each of the sample transcripts by allowing individual
interpretations to be offered, challenged, and resolved in order
to refine thematic categories. We then merged these six collabo-
rative analyses to form a comprehensive coding scheme for the
data. The coding scheme was applied to two further transcripts
by all authors for the purpose of refinement. Remaining
transcripts were divided between authors for detailed analysis.
Results and discussion
Our results reveal the complexity of interaction between the
evaluation of a telehealthcare service and its development. Here,
we outline some of the major processes that emerged as evalua-
tors struggled to integrate these tasks.
Evaluating the system: operationalising clinical practice
Evaluation generally involves producing knowledge about
attributes of a new service or technology that relate to its poten-
tial effectiveness from various perspectives. The task of
constructing measures to assess these attributes is further
complicated if the research is conducted in parallel with service
development. It requires not only identifying and specifying
existing clinical knowledge and practices, but also anticipating
ways in which practices will be changed in the new system and
designing research instruments that capture such changes. Our
respondents spoke of “hard” and “soft” outcomes in ways that
prioritised quantitative methods of evaluation, assuming that
“hard” outcomes were those that mattered most. However,
participants found it difficult to define clinical knowledge and
practices in terms that permitted such measurement (see box 2).
This problem extended beyond measuring clinical outcomes to
other effects of the telehealthcare system, such as patients’ and
professionals’ views and particularly to the cost effectiveness of
telehealthcare.
The difficulties experienced in defining clinical practice con-
tributed to another problem for evaluation—recruitment.
Although this problem is certainly not specific to telehealth-
care,19 we find here a particular impediment to recruitment, as
clinicians using the telehealthcare system come to identify more
and more characteristics of patients and their conditions that
make them inappropriate candidates for telehealthcare (see box
3). The experience described here is common to other
telehealthcare projects. It seems to reflect a growing understand-
ing of the limited capacity of telehealthcare systems to
accommodate clinical practice in the way that it is routinely
enacted. Increasing exclusion criteria not only reduces the possi-
bility of achieving recruitment targets but, more importantly,
limits the claims that can be made for the effectiveness of the tel-
ehealthcare system for the broader patient population (box 3).
Managing conflicting demands of service provision and
evaluation
Integrating service development with evaluation often requires
clinical staff to perform additional research tasks. Evaluators
expressed difficulties in ensuring complete and accurate data
collection, because clinicians were inexperienced in research or
Box 1: Details of seven telehealthcare evaluation projects
examined (medical specialties omitted to preserve
anonymity)
Site 1: Store-and-forward system between primary and
secondary care
Evaluation—Pragmatic service evaluation, survey of users’ views
Problems—Long delays in set up, technical problems
Outcome—Project successfully completed but not intended for
routine service delivery.
Site 2: Real time video based system between primary and
secondary care
Evaluation—Randomised controlled trial of clinical effectiveness
(intended), qualitative study of users’ views (actual)
Problems—Problems with staffing and time commitments
Outcome—Randomised controlled trial not done
Site 3: Real time, video based system between hospital
department and community
Evaluation—Randomised controlled trial, economic evaluation,
qualitative study of users’ views
Problems—Problems with the technology, cost constraints, initial
professional resistance
Outcome—Project continuing
Site 4: Store-and-forward system between primary and
secondary care
Evaluation—Randomised controlled trial of clinical and cost
effectiveness, qualitative study of users’ views
Problems—Major problems with recruitment, professional
resistance
Outcome—Project completed
Site 5: System based on data transmission within secondary
care
Evaluation—Pragmatic service evaluation intended (to assess
utility and users’ views)
Problems—Financial constraints, logistical problems of
coordination
Outcome—Project failed
Site 6: Mixed system (video and data transmission)
Evaluation—Multicentre randomised controlled trial (clinical
outcomes and cost measures)
Problems—Some problems with recruitment, but viewed as
successful
Outcome—Project continuing
Site 7: Real time video-based system
Evaluation—Pragmatic service evaluation (assessing clinical
effectiveness and users’ views)
Problems—Some equipment and logistical difficulties
Outcome—Project continuing
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did not have time to complete both clinical and research duties
(see box 4). Research is often not considered a priority when it
competes with the demands of service provision. The
importance of accommodating everyday “workability” within a
trial design is shown by the dilemma posed when nurses working
an “extra” telehealthcare service felt that the trial created obliga-
tions that compromised their role as care providers by placing
unmanageable demands on their time (box 4).
A major part of the conflict around service provision and
evaluation concerned the management of risk. In routine
settings, clinical practice is based on minimising risks to patients.
For clinicians in this study, the introduction of a telehealthcare
system and its evaluation highlighted the possibility of increased
risk from what they perceived as new forms of practice.
Clinicians involved in telehealthcare evaluations were thus faced
with a dilemma: they had concerns about patient safety and their
own personal liability (see box 5) but needed to engage with
these new technologies in order to prove their safety.
In the evaluations we examined, ensuring that the system was
safe was clearly the priority. Often individual clinicians managed
perceived risk to patients by reverting to the default model of
service provision (box 5). At site 1 (providing the first quote in
box 5), this focus on risk minimisation meant that 60% of
patients had to be recalled to a conventional doctor-patient
encounter. The priority of clinical safety therefore needed to be
built into the research protocol: clinicians needed flexibility to
exercise their judgment and revert to standard care if they con-
sidered a patient was at risk, though too much flexibility could
invalidate the research. At site 3 (the second quote in box 5), it
became apparent that an unexpectedly large proportion of eligi-
ble patients were being excluded because of healthcare
providers’ concerns about clinical risk and their lack of
confidence in using the new system. Thus, professional
assessments of risk attributed to the system were perceived and
acted on in ways that could (and did) adversely affect evaluation.
Making sense of study findings
Accurately understanding the effects of a telehealthcare system is
essential if the study results are to inform further service
development. However, we observed that some evaluators found
it difficult to determine how much the results of their study
reflected effects of the telehealthcare system and how much they
were a product of the research process and the disruption to
normal practice that was caused by it (see box 6). Clinicians and
researchers themselves recognised these limits, knowing that
their studies reflected experimental work that was sometimes
Box 2: Constructing outcome measures
“Trying to evaluate a [medical specialty] service as an outcome
measure is very difficult, because we don’t have very many,
particularly for the majority of conditions that we look at,
[names] For cancer, you can do, because you look at the
recurrence rates and all the rest of it; but [names] there aren’t
cures for it so you’re looking at things that are much softer as far
as outcome, mainly around issues involving quality of life and
patient satisfaction.”—Clinical leader, site 1
“If you’re doing HTA [health technology assessment] in the
rather broader sense [than clinical trials] [the studies are]
additionally complicated. You cannot usually do a randomised
trial, you have to do some other sort of design, you have to create
your own measures. You can’t just be satisfied with, ‘Oh it’s all
right, mortality is the measure for a cancer trial,’ it’s a key
measure, the other ones are fairly clearly spelt out, you’ve got to
create measures. And I think if you add to that the problems of
doing informatics research in general, as opposed to
telemedicine in particular, I think you’ve got a whole series of
other issues to do with attempts to apply clinical paradigms to
informatics research.”—Clinical leader, site 4
Box 3: Recruitment of patients and validity of results
“Really, in the last two months or so I’d say that recruitment has
slipped, certainly at our site, because the winter months tend to
generate more patients [with the condition], and what I’m
finding, though, is that they’re either end stage . . . and they’re just
too sick, there’s no way that they could manage with equipment
at home, they’re more respite care really. All the patients have just
said no, they just don’t want anything to do with it.”—Research
nurse, site 6
“The recruitment’s a crucial issue, not just for the actual
achievement of numbers but also for the external validity, which I
think is very important.”—Clinical leader, site 4
Box 4: Managing conflicting demands of service
provision and evaluation
“Partly, but I think the GPs say that there are two things that have
added to their burden, and they find it difficult to say which is
worse. One is the actual telemedicine, and the other is the
research bit, including the ethics bit.. . . The telemedicine has
added to their work, but it would have been easier if they’d just
been implementing a telemedicine project. I can actually see that
if you can produce a telemedicine project that makes GPs’ lives
easier they’ll like it, but nobody will ever learn anything about
it.”—Clinical leader, site 4
“And the trouble really is, just because the equipment was late
coming we were then trying to start at peak time [for this
condition] which means that at [the hospital] there they’re just
lined up on trolleys, so it’s very hard for the nurses to say, ‘Sorry,
we’re not going to see this patient because we’re doing this
trial.”—Clinical leader, site 3
Box 5: Managing risk by protocol
“But there is incorrect diagnosis all the time.” (Interviewer)
“But diagnosis incorrect through a telemedicine application—and
should that individual have been brought in to the hospital to
have it checked and was the amount of information you actually
physically had to make the diagnosis sufficient without bringing
the patient in? And probably misdiagnosis could be slightly
higher.... Then it needs to come down on the basis of what’s the
protocol for lesions—and that the protocol may be that we
actually say that, for the doctor to have the degree of confidence,
that he would ask the patient to strip so he can actually look at
the whole of the body and to ask the question ‘Have you got any
more lesions in any other place?’ Now would that sort of process
stand up then in court that ‘Yes, we’ve gone through this process,
this is the protocol for lesions, and we follow it to the law’ and the
doctor has a degree of confidence that the nurse actually follows
that protocol.”—Service manager, site 1
“We will be monitoring how often [they default to standard care],
but they’re allowed to do that so I don’t think safety will be an
issue. But the issue of safety is something we’ve taken extremely
seriously, and that’s just to do with the lack of knowledge about
the legal status of telemedicine. So we’ll be erring on the side of
overcautious in terms of how our protocol is set up because we
definitely don’t want to ever be putting a patient at risk at all, in
any shape or form.”—Clinical leader, site 3
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considerably different from the experience of normal service
provision. Difficulty in interpreting effects of the new systems was
also sometimes a product of knock-on effects through different
levels of service provision and depended greatly on which
perspective of “effectiveness” was being considered (box 6). The
problem of judging effectiveness was an ongoing problem for
telehealthcare evaluators and contributes to the broader
problem of translating research findings into everyday practice.
Randomised controlled trials versus pragmatic evaluation
The dominance of the randomised controlled trial (RCT) as the
“gold standard” of medical research is clearly apparent in our
research (box 7). In practice, however, many respondents
re-evaluated the appropriateness of randomised controlled trials
for assessing telehealthcare, having expressed disappointment
about progress or uncertainty about the outcomes of their
projects. Participants in studies applying such formal study
designs found that trying to impose sufficient constraint on the
system for the purpose of measurement conflicted with the
dynamic nature of the health service environment, where some
flexibility is necessary (see box 7).
The need for more pragmatic approaches to the evaluation
of telehealthcare systems was thus apparent. Evaluators who had
adopted non-randomised designs felt they were producing
results they could use, even though they too experienced
problems with integrating telehealthcare systems into existing
practice. However, because they were less restricted in their
evaluation approaches, they were able to modify both clinical
practice and technical systems more readily, and so improve the
stability of the project overall. In doing so, respondents often
drew a distinction between two types of knowledge—
experimental quantitative knowledge about outcomes, and
experiential qualitative knowledge about workability (see box 8).
They regarded the former as having higher status, and saw its
publication as the main objective of their work, but found the lat-
ter to be more useful, particularly for judging the utility of the
system in practice but more generally for informing service
development. These findings have important implications for
commissioning processes, which must permit greater acknowl-
edgement of the practical value of research methods that
produce knowledge about processes rather than healthcare out-
comes.
Conclusion
The complexity of a combined implementation and evaluation
of a telehealthcare system is often underestimated in both the
design and the conduct of evaluation studies. The requirement of
stability for the evaluation protocol conflicts with the need for
flexibility in the provision of health services to individual
patients. This tension raises particular methodological issues,
which centre around defining and measuring clinical practice,
managing conflict between evaluation and service provision, and
difficulty in interpreting study findings. Evaluating telehealthcare
thus requires more pragmatic and flexible approaches to the
production of evidence than those permitted within the rigid
structures of controlled study designs. The issues identified in
this paper, such as workability, must be given greater attention in
the design of evaluation studies in order to improve both the
quality of such research and its relevance for clinical practice.
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Box 6: Ambiguity in attribution of effects
“I think what it’s not brought out, or we can’t conclusively draw
out, is whether it has been the trial and all the problems with the
trial or whether it’s the telemedicine per se, and I think that’s a
big problem and that’s what I’m having to write up—that we’re
not quite sure.”—Research associate, site 4
“Yes, but the thing is, you see, like all these things in life, it’s not
where the truth lies, it’s where it’s perceived to lie. They see the
waiting list numbers going down, therefore it’s working, that’s the
simple equation. Because all they’re concerned about is numbers
on the waiting list, because that’s what they get the pressure
upon.”—Clinical leader, site 1
Box 7: Randomised controlled trials versus pragmatic
evaluation
“I think you need a randomised study to evaluate it in general. I
think you need some form of controlled comparison, and RCTs
give you that. And the associated rigor, I think, is important
because it’s very easy for technology to develop it’s own inertia,
and it’s happened time and again in healthcare that technologies
have been adopted when really they don’t stand up to a rigorous
evaluation. So in that sense an RCT I would see as being the
definitive evaluation.”{Statistician, site 3
“I suppose there’s a bit of a worry about that—that we’ve suddenly
introduced something that’s slightly different to the protocol. But
I think, given the way recruitment has been running quite low,
the trial again is pragmatic rather than explanatory. It’s
telemedicine being installed and taking the pictures and the
camera—the process more than the actual pinning it down where
you take the pictures in this form, that form, send them down this
type of telephone line in these ideal conditions using this camera.
I think we’re never really going to get that; we’re going to say it’s
the policy of telemedicine in this format that is broadly the same,
or not as the case may be, as gold standard outpatients’
appointment.”{Statistician, site 4
Box 8: Different forms of knowledge
“It sounds like you’re saying that you feel that the research won’t
necessarily tell you the answers you want in terms of ‘Is this
useful?’”—Interviewer
“No, no, I think it will. I think it’s the other way round. I think it
probably won’t tell me ‘Yes it’s useful,’ but hopefully it will tell me
it’s not dangerous. So it won’t be able to demonstrate that it’s
useful—that will be up to me to say whether it’s useful or not—but
it should be able to tell me that I’m not putting patients at
risk.”—Clinician, site 7
“And how will you judge whether it’s useful?”—Interviewer
“By seeing how positive we feel about using it. Because if it really
is an effort to use it then it will turn out to be not useful, because
it won’t get used.”—Clinician, site 7
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What is already known on this subject?
Telehealthcare is a rapidly growing field of clinical activity
and technical development
New technologies offer clinicians and policy makers the
potential to solve structural problems around inequalities of
service provision and distribution
Despite many pilot studies, telehealthcare has not yet
penetrated practice in any systematic way
What this study adds
This ethnographic study of seven telehealthcare evaluation
projects identified key difficulties that are experienced when
evaluation and development of a telehealthcare service are
combined
More pragmatic approaches to evaluation would improve
both the quality of such research and its relevance for
service provision in the NHS
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